Premium
Poor metabolizer status at the cytochrome p450 2c19 and 2d6 loci does not modulate susceptibility to therapy‐related acute myeloid leukaemia
Author(s) -
Roddam Philippa L.,
Allan James M.,
Rollinson Sara,
Smith Alexandra G.,
Willett Eleanor V.,
Swirsky David,
Roman Eve,
Morgan Gareth J.
Publication year - 2003
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1046/j.1365-2141.2003.04245_3.x
Subject(s) - cyp2c19 , chemotherapy , gstp1 , biology , myeloid , pharmacology , melphalan , oncology , cancer research , immunology , medicine , genotype , genetics , gene